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Marfan Syndrome
An Ongoing Discussion*
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Amsterdam and Utrecht, the Netherlands
Pregnancy in patients with Marfan syndrome remains a con-
troversial subject. The 2010 thoracic aortic disease guidelines
advocate avoidance of pregnancy if the aortic root diameter
exceeds 40 mm and recommend prophylactic aortic root
replacement in those who desire pregnancy (1). However, they
are not entirely in line with the European and Canadian
guidelines, which report an aortic root diameter of45 mm to
e considered safe (2,3). This discrepancy in guidelines is
aused by a lack of sufficient studies in the current literature.
nly 2 prospective studies have been performed to assess the
mpact of pregnancy on aortic growth and aortic complications
n women with Marfan syndrome (4,5).
See page 224
Therefore, the new prospective study of Donnelly et al. in
98 women with Marfan syndrome is very interesting (6).
The aim of this study was to assess the impact of pregnancy
on the rate of aortic growth as well as on short- and
long-term clinical outcomes. Of the 98 women, 69 women
had 199 pregnancies, and 35 women with 55 pregnancies
could be followed prospectively during their pregnancy with
multiple cardiac echoes, of which 14 entered pregnancy with
an aortic root diameter 40 mm (range 40 to 51 mm).
Data on 2 clinical outcomes were recorded: 1) a compos-
te adverse outcome, defined as death, aortic dissection, or
evere symptomatic aortic regurgitation necessitating urgent
urgery; and 2) the need for elective aortic surgery during
he period of clinical follow-up.
Of the 199 pregnancies there were 170 live births, 26
pontaneous abortions, and 2 ectopic pregnancies. The number
f pregnancies ranged from 1 to even 12 (median 3).
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relevant to the contents of this paper to disclose.No acute aortic dissections were observed during all
pregnancies. Two women developed symptomatic carotid
artery dissections and 1 patient showed worsening of aortic
regurgitation from mild to severe at 38 weeks’ gestation with
a 49-mm aortic root, necessitating aortic root replacement
at 6 months post-partum.
There was a significantly higher rate of aortic growth
documented during pregnancy compared with each wom-
an’s prior baseline aortic growth rate. The prevalence of
both adverse outcome and elective aortic surgery during
long-term follow-up was higher in those women who had a
prior pregnancy compared with the matched childless
group. On multivariate analyses, initial aortic root diameter
and rate of change in aortic diameter (log) were the only
independent predictors of long-term adverse cardiovascular
outcome.
Many case reports and retrospective studies have been
published about aortic dissection during or immediately
following pregnancy in women with Marfan syndrome
(7,8). In these studies, however, there is a large selection
bias because many of these women were unknown with
Marfan syndrome at the time of pregnancy and therefore
preconception aortic diameters are lacking. A great deal is to
be gained if health providers caring for women at childbear-
ing age recognize women with Marfan syndrome. Screening
programs by a multidisciplinary team should therefore be
easily accessible.
If we combine the only 3 prospective studies in the
current literature, no type A dissections were reported
during 145 pregnancies in 78 nonoperated women with
Marfan syndrome. During 29 pregnancies 25 women had an
aortic root diameter 40 mm (range 40 to 51 mm) (4,5,6).
However, there were 4 major cardiovascular complications;
1 type B dissection, 2 carotid artery dissections, and 1
patient who experienced worsening of aortic regurgitation
from mild to severe.
For women who had aortic root replacement before
pregnancy there are even less prospective data available. In
the 3 prospective studies there were only 5 women with a
previous aortic root replacement throughout 6 pregnancies.
Three women had an elective aortic root replacement (2
valve-sparing and 1 Bentall) and 2 women had a emergency
root replacement for type A dissection (Bentall) limited to
the ascending aorta. Both women with a limited type A
dissection developed type B dissection during pregnancy
and in both women with a valve sparing operation, preg-
nancy was complicated by progressive aortic regurgitation.
In unoperated patients with Marfan syndrome, natural
aortic growth and aneurysm formation have been studied in
children and adults (9,10). Rapid aortic growth may occur in
a small subset of patients (men 15% and women 11%) and
has been shown to be a risk factor for aortic dissection (9).
Initial aortic diameter, a distensibility 3  10–3 mm Hg–1
in the thoracic descending aorta (11), previous aortic root
replacement, hypertension, and aortic regurgitation have
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July 17, 2012:230–1 Pregnancy and Marfan Syndromebeen identified as predictors for rapid aortic growth (12,13).
rowth of the aortic root is a normal phenomenon in
ealthy women during pregnancy. The maximum diameter
s reached during the third trimester; but still 6 weeks
ost-partum the diameter remains enlarged by an average of
mm (14). The study of Donnelly et al. (6) is the first
rospective study to show a significant increase in aortic
rowth in woman with Marfan syndrome during pregnancy
ompared to baseline. Compared with the other 2 prospec-
ive studies (4,5) this patient cohort was larger and had a
reater number of pregnancies per woman (mean 3 vs. 2
regnancies in the studies of Meijboom et al. [5] and
ossiter et al. [4], respectively). Moreover, there might have
een a different strategy in the use of beta-blockers, al-
hough the overall use of beta-blockers was rather low in all
studies (between 30% end 40% to some extent). Although
he influence of pregnancy on aortic root growth was
ignificant, the quantitative effects are still small (0.7 to 3
m per pregnancy).
Not much is known about the long-term effect of
regnancy on the cardiovascular status of women with
arfan syndrome. In the study of Donnelly et al. (6),
omen with a prior pregnancy had a significantly worse
utcome and more often elective surgery during long-term
ollow up (6). This was in agreement with our study where
regnancy appeared to have a small but significant influence
n long-term aortic root growth in women with an aortic
oot diameter 40 mm (5). In clinical practice this would
ean an average aortic root growth of 7 mm versus 3 mm
n 20 years.
In conclusion, women with Marfan syndrome without
revious cardiac complications seem to tolerate pregnancy
ell, up to an aortic root diameter of 45 mm, with good
linical care before, during, and after pregnancy. Pregnancy
hould be discouraged in women with previous aortic
issection because of the high risk for aortic complications.
regnancy causes a slight increase in aortic root diameter. In
he long run women with enlarged aortic root diameters at
regnancy, show a slightly accelerated aortic root growth
nd therefore will have elective aortic root surgery at a
ounger age. In all women, especially with enlarged aortic
oot diameters, the pros and cons of pregnancy should be
ully discussed as well as the alternatives (childlessness,
doption, and surrogate pregnancy).Reprint requests and correspondence: Dr. Barbara J. M. Mulder,
AMC, Cardiology, Meibergdreef 9, Room B2-240, Amsterdam,
Noord-Holland 1100 DD, the Netherlands. E-mail: b.j.mulder@
amc.uva.nl.
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